ReviewCardiovascular endocrinology & metabolism2026

Effect of glucagon-like peptide-1 receptor agonists on major adverse cardiovascular events in adults with type 2 diabetes and established atherosclerotic cardiovascular disease: systematic review and meta-analysis of randomised trials.

Alejandro Montenegro-Avila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.